<i>Genes, Cells and Brains</i> by Hilary Rose and Steven Rose - Review
By Steven Poole,
The Guardian (UK)
| 12. 19. 2012
We have outsourced the job of interpreting ourselves to the modern life sciences. The decoding of the human genome will tell us who we really are, pledged the gene-merchants. Brain scans will tell us who we really are, swore the neuro-hustlers. And what did we get? We got suckered. It turns out that humans have roughly as many protein-encoding genes as a fruit fly, and that
fMRI scanning is still such an inexact art that a team of satirical neuroscientists have demonstrated significant "brain activity" in a dead salmon.
This fascinating, lucid and angry book by the sociologist Hilary Rose and the neurobiologist Steven Rose (they are married) boasts abundant targets and a lethally impressive hit ratio. They decry the entrepreneurialisation of science – "wealth creation is now unabashedly formalised as the chief objective of science and technology policy" – not least because it actually impedes science. ("PhD students can work for months on a project only to find that they cannot continue as they have run into a patent.") They lambast the "armchair" theorising of evolutionary psychology, with its...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Robert Resta, The DNA Exchange | 07.22.2024
Medical geneticists and genetic counselors have an often complicated and at times tense relationship with people with disabilities, their families, advocates, and scholars. Geneticists are strong advocates and supporters for all of their patients, regardless of their abilities and disabilities...
By Katherine Bourzac, Nature | 07.10.2024
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...